Key result
Transcatheter aortic valve replacement is an effective, minimally invasive treatment for symptomatic severe aortic stenosis, with expanding indications across surgical risk categories and improving device technology.
Why the study?
Patient populations benefiting from TAVR continue to expand, accompanied by ongoing advancements in techniques, technology, and outcomes.
This review highlights advances in vascular access, valve design, and procedural complication reduction in transcatheter aortic valve replacement.
Broadens TAVR use across risk strata; confirms advances but leaves long-term durability and optimal device selection open.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive approach to treat symptomatic severe aortic stenosis. The patient populations that have been shown to benefit from this procedure continue to grow with time. Techniques and technology in TAVR persistently advance with a continued trend toward improved outcomes for patients. In this review, we highlight the advances in vascular access, TAVR valve design, progress in reducing procedural complications, and emerging evidence in the field.
No takes yet. Share an insight, caveat, or question.
Randall et al. (2020) conducted a review in Severe aortic stenosis. Transcatheter aortic valve replacement (TAVR) vs. Surgical aortic valve replacement (SAVR) or medical therapy was evaluated. Transcatheter aortic valve replacement is an effective, minimally invasive treatment for symptomatic severe aortic stenosis, with expanding indications across surgical risk categories and improving device technology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: